Home Birth Safety

The Birthplace in England Study is the largest prospective study ever conducted of where to give birth. The research team enrolled 64,538 low-risk women in the UK and tracked outcomes across four planned birth settings: home, freestanding midwifery unit, alongside midwifery unit, and obstetric (hospital) unit.

The headline finding for experienced mothers, those who had given birth before, was that there was no significant difference in adverse perinatal outcomes between settings. The interventions told a different story. Women planning home birth had an 88 percent normal birth rate. Women planning hospital birth had 58 percent.

Cesarean rates ranged from 0.6 to 5.1 percent at home compared with 6.5 to 15.5 percent in hospital. The study was funded by the UK Department of Health and reviewed by independent statisticians.

The Birthplace study reported a different result for first-time mothers (nulliparous women). The adverse perinatal outcome rate was 9.3 per 1,000 for planned home births compared with 5.3 per 1,000 for planned hospital births. That gap, while small in absolute terms, is statistically significant.

The transfer rate from home to hospital during labor was 45 percent for first-time mothers, compared with around 10 to 15 percent for experienced mothers. This is the strongest evidence in the home birth literature that home birth is not equally appropriate for all populations. Most maternity care systems internationally treat first-time mothers and experienced mothers differently when discussing home birth as an option.

The Netherlands keeps national-level data on home birth because home birth is an established part of their maternity system, accounting for roughly 16 to 20 percent of births during the years studied. The de Jonge papers in BMJ 2009 and 2013 covered 529,688 births, drawing on every low-risk delivery in the country.

The results showed no increased perinatal mortality at planned home birth compared with hospital. The maternal morbidity numbers were better at home.

Severe maternal morbidity for women who had previously given birth was 1.0 per 1,000 at home versus 2.3 per 1,000 in hospital. Postpartum hemorrhage was 19.6 per 1,000 at home versus 37.6 per 1,000 in hospital. The Dutch system is built around the home-birth-as-default model with clear referral paths, which is part of what allows these outcomes.

The Janssen study used British Columbia provincial data on 12,972 births to compare three planned settings: midwife-attended home birth, midwife-attended hospital birth, and physician-attended hospital birth. Perinatal death rates were 0.35 per 1,000 at home, 0.57 per 1,000 with midwife in hospital, and 0.64 per 1,000 with physician in hospital. The home setting had the lowest death rate of the three. Interventions told the expected story.

Home births used 68 percent less electronic fetal monitoring, 59 percent fewer assisted (vacuum or forceps) deliveries, and 38 percent fewer postpartum hemorrhages requiring intervention. The Canadian system, like the Dutch, integrates midwives into the public system with clear referral pathways.

The Hutton team published a systematic review and meta-analysis covering roughly 500,000 home births across multiple countries with integrated midwifery systems. The pooled finding: in well-integrated maternity systems, planned home birth shows no significant difference in mortality compared with planned hospital birth. The qualifier matters.

The result depends on the presence of qualified midwives, regulated home birth standards, and clear referral pathways into hospital when needed. In settings without those structures, the safety equation looks different. This is a key reason why US home birth statistics, where regulation varies dramatically by state, are harder to interpret than European data.

The Midwives Alliance of North America runs a voluntary registry of US home births attended by certified professional midwives. The 2014 paper published in the Journal of Midwifery & Women's Health analyzed 16,924 planned home births from the registry.

Outcomes: 93.6 percent of women had a spontaneous vaginal birth. The cesarean rate was 5.2 percent compared with the US national average of 32.5 percent. VBAC success at home was 87 percent.

At six weeks postpartum, 86 percent of mothers were exclusively breastfeeding. The registry data has limitations because participation is voluntary and selection effects can favor better-than-average outcomes, but the sample is large enough that the directional findings hold across multiple sensitivity analyses.

The 2010 Wax meta-analysis became the most-cited anti-home-birth study in US obstetrics because it reported a tripled neonatal mortality rate for planned home birth. The paper was formally investigated and found to have serious methodological flaws.

It failed to distinguish planned home birth from unplanned home birth (women who delivered at home accidentally), included only 64 neonatal deaths when 200 to 400 would have been needed for the conclusions to hold statistical power, included studies the authors had already reported as having data errors, and counted breech and twin births in the home-birth arm even though those would have been hospital-transferred in any actual home birth system. Despite the formal critique, the American College of Obstetricians and Gynecologists continues to cite the study in its position papers.

The UK National Institute for Health and Care Excellence is the country's official body for developing evidence-based clinical guidelines. NICE Guideline NG235, issued in 2023, formally identifies planned home birth as "particularly suitable" for low-risk multiparous (experienced) mothers. The guideline directs healthcare providers to offer women a choice of four settings: home, freestanding midwifery unit, alongside midwifery unit (attached to a hospital), and obstetric unit.

Each setting is presented with its specific risks and benefits, and the woman is supposed to make an informed choice. The US does not have an equivalent national guideline. ACOG officially considers hospital the safest setting and does not endorse offering home birth as an equal option, despite the underlying evidence base being identical.

Two recent European studies measured how women experience the birth itself, separate from clinical outcomes. The Irish 2023 study asked women to rate their trust in their provider on a 10-point scale. Women who gave birth at home rated trust at 9.9 out of 10.

Women who gave birth in hospital rated it at 5.0. The Greek 2025 study used a standardized Respect Index measuring how women felt they were treated. Home births scored 74.4 on an 80-point scale. Hospital births scored 56.4. These are large effects by any social-science standard. Satisfaction is not a clinical outcome, but it is the outcome women report as mattering most when asked what made their birth a positive or negative experience.

The Pew Research Center tracked US home birth rates over time. Home births rose 77 percent between 2004 and 2017. They rose another 19 percent during the COVID period.

In 2021, 1.41 percent of US births took place at home, the highest rate since 1990.

The growth has been driven primarily by white, educated, higher-income women, but the rate of increase has been steepest among Black women, who are responding to the racial disparities in hospital outcomes that show up across the maternity care data. Pew's analysis did not assess outcomes, just rates. The trend is one of the few statistics in US maternity care that is moving in a direction the public health establishment would broadly consider positive.